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Introduction
Pancreatic -cell dysfunction and insulin resistance are the hall-
mark of type 2 diabetes. Various inflammatory cytokines and oxida-
tive stress produced by islet-infiltrating immune cells have been
proposed to play an important role in mediating the destruction of
 cells [1, 2]. Diabetes has also been considered as an oxidative
inflammatory disorder due to malnutrition characterized by an
increased intake of total and n-6 fats and decreased intake of n-3
fats and antioxidants. Malnutrition in the modern diet induces
oxidative stress and activates the immune system resulting in
immune suppressive, pro-inflammatory and thrombogenic lipid
metabolites [3]. 
Improving immune function has been used as a strategy to
improve diabetes. For example, immuno modulators, or cytokine-
inducers have been tried to prevent insulin-dependent diabetes
mellitus (IDDM) and also non-insulin-dependent diabetes mellitus
(NIDDM) in animal models [4]. Both exercise and caloric restric-
tion, known to be able to improve diabetes, have been shown to
affect the phagocytic activity of macrophages in the Zucker rat
(fa/fa), a model for the study of immune function in type 2 dia-
betes mellitus [5].
The non-obese Goto-Kakizaki (GK) rat is a model of type 2 dia-
betes with an early manifestation of symptoms at 4–6 weeks after
birth. This model was established from normal Wistar rats by
selectively breeding the animals with signs of impaired glucose
tolerance and is characterized by hyperglycaemia, impaired glu-
cose tolerance, abnormal hepatic glucose production, insulin
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Abstract
The development of type 2 diabetes is accompanied by decreased immune function and the mechanisms are unclear. We hypothesize
that oxidative damage and mitochondrial dysfunction may play an important role in the immune dysfunction in diabetes. In the present
study, we investigated this hypothesis in diabetic Goto-Kakizaki rats by treatment with a combination of four mitochondrial-targeting
nutrients, namely, R--lipoic acid, acetyl-L-carnitine, nicotinamide and biotin. We first studied the effects of the combination of these
four nutrients on immune function by examining cell proliferation in immune organs (spleen and thymus) and immunomodulating fac-
tors in the plasma. We then examined, in the plasma and thymus, oxidative damage biomarkers, including lipid peroxidation, protein
oxidation, reactive oxygen species, calcium and antioxidant defence systems, mitochondrial potential and apoptosis-inducing factors
(caspase 3, p53 and p21). We found that immune dysfunction in these animals is associated with increased oxidative damage and 
mitochondrial dysfunction and that the nutrient treatment effectively elevated immune function, decreased oxidative damage, enhanced
mitochondrial function and inhibited the elevation of apoptosis factors. These effects are comparable to, or greater than, those of the
anti-diabetic drug pioglitazone. These data suggest that a rational combination of mitochondrial-targeting nutrients may be effective in
improving immune function in type 2 diabetes through enhancement of mitochondrial function, decreased oxidative damage, and
delayed cell death in the immune organs and blood.
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resistance, defects in insulin secretion [6, 7], decreased exploratory
activity and learning impairments [8], mitochondrial dysfunction
[9, 10] and increased mitochondrial susceptibility to oxidative
stress [11]. However, no studies have been carried out in this dia-
betic model either to investigate the immune dysfunction or to
improve immune function with mitochondrial-targeting nutrients.
We have investigated the preventive effects of a combination of
four mitochondrial-targeting nutrients [12], namely, R--lipoic
acid, acetyl-L-carnitine, nicotinamide and biotin, in GK rats. It was
found that this nutrient treatment improved glucose tolerance,
insulin release, fatty acid metabolism and mitochondrial biogene-
sis and function in the skeletal muscles of the diabetic rats (Shen
et al. submitted for publication). Based on these results, we
 propose that oxidative damage and mitochondrial dysfunction
may play an important role in immune  dysfunction in this diabetic
model and that these mitochondrial nutrients may improve
immune function through the mechanisms of decreasing oxidative
damage and improving mitochondrial function. 
In the present study, we first compared the immune functions
of Wistar rats and GK rats by examining cell proliferation in the
immune organs spleen and thymus, and by measuring the
immunomodulating factors adiponectin, C-reactive protein
(CRP) and tumour necrosis factor- (TNF)- in plasma. We then
compared, in plasma and/or  thymus, oxidative damage biomark-
ers, antioxidant defence  parameters, mitochondrial membrane
potential (MMP) and apoptosis-related factors. The oxidative
damage biomarkers include lipid peroxidation, protein oxidation,
reactive oxygen species (ROS) and calcium. The antioxidant
defence  parameters include total antioxidant capacity (T-AOC),
glutathione (GSH), glutathione S-transferase (GST) and super-
oxide dismutase (SOD). The apoptosis-related factors include
caspase 3, p53 and p21. 
Materials and methods
Animals and treatments
Four-week-old male diabetic GK rats together with age-matched male non-
diabetic Wistar rats were purchased from SLAC Laboratory Animal Co. Ltd
(Shanghai, China). All animals were housed at 23 ± 2°C under 12 hrs light
and dark cycles, and allowed access to food and water ad libitum. The
experiments were performed in accordance with the Guidelines for Animal
Experiments of the Institute for Nutritional Sciences, Chinese Academy 
of Sciences.
Five groups of rats (10 animals in each group) consisted of two con-
trol groups, Wistar and GK, and three GK treatment groups. A pioglitazone
group received pioglitazone 20 mg/kg/day by gavage; a low-dose nutrient
group received a combination of R-LA 50 mg/kg/day, ALC 100 mg/kg/day,
biotin 0.1 mg/kg/day and nicotinamide 15 mg/kg/day by gavage; and a
high-dose nutrient group received the same combination of nutrients as
the low-dose group, but at a 10 times higher dosage. The control groups
received the same gavage volume of phosphate buffered saline (PBS)
alone. The treatments were started at 6 weeks of age and continued for 
3 months. At approximately 18 weeks of age, animals were anaesthetized
with an intraperitoneal injection of sodium pentobarbital (60 mg/kg) and
sacrificed for obtaining plasma, spleen and thymus.
Sample preparation and maintenance
Blood samples were collected by cardiac puncture, with anticogulating
agent ethylenediaminetetraacetic acid (EDTA). Each blood sample was
centrifuged at 1200 g for 10 min. The plasma was taken out and stored
at –80C until analysis. Spleen and thymus were aseptically removed,
gently squashed between two glass slides, and the erythrocytes were
lysed with Tris-NH4Cl (17 mM Tris/136 mM NH4Cl, pH 7.2) for 5 min. at
room temperature, then centrifuged at 1200 g at 4°C for 10 min. The
pelleted lymphocytes were re-suspended with RPMI 1640 medium
(Invitrogen, GIBCO, Carlsbad, CA, USA) with 10% foetal bovine serum
and prepared as a single-cell suspension. One part of the lymphocytes
was placed in complete RPMI 1640 medium with foetal bovine serum
for assaying proliferation, ROS and MMP. The other part was washed
and homogenized in ice-cold isotonic saline. The homogenates were
then centrifuged at 10,000 g for 10 min. at 4°C. The supernatant was
collected for assaying the biochemical parameters. Protein concentra-
tions were determined using the BCATM Protein Assay kit with bovine
serum albumin (BSA) as the standard. 
Assessment of splenocyte and thymocyte 
proliferation and thymus index
The proliferation ability of lymphocytes extracted from spleen and 
thymus was measured by the 3-(4,5-dimethylthiazol-2-yl)-2, 
5-diphenyl-2H-tetrazolium bromide (MTT) method [13]. We used the
MTT assay because the results can be quickly read on a multi-well scan-
ning spectrophotometer (ELISA reader) and show a high degree of pre-
cision without using radioisotopes [14]. In brief, lymphocytes from spleen
and thymus were prepared aseptically immediately after isolation. A 
single-cell suspension was prepared and adjusted to 2  106 cells/ml.
Aliquots (100 l) of lymphocytes were seeded into a 96-well microplate
in the presence of the mitogen concanavalin A (10 g/ml; Sigma, St Louis,
MO, USA). The plate was incubated for 48 hrs at 37°C in a humidified
5% CO2/air mixture. After the addition of 10 l of MTT per well, the plate
was incubated for an additional 4 hrs, and then 100 l of 20% (w/v) 
SDS (Sigma) was pipetted into each well. After overnight incubation at
37°C in 5% CO2 atmosphere, the microplate was read at a wavelength
of 570 nm. The thymus index was expressed as the thymus weight rel-
ative to body weight (mg/g).
Detection of plasma immunomodulating 
parameters
Plasma adiponectin was determined by enzyme-linked immunosorbent
assay (ELISA) with a commercially available rat Adiponectin ELISA Kit
(ADL, USA) using a plasma volume of 100 l; a rat TNF- ELISA kit
(BioSource, Camarillo, CA, USA) using a plasma volume of 50 l diluted
twofold, and a rat CRP ELISA kit (RapidBio, CA, USA) using a plasma 
volume of 10 l diluted 50,000-fold. All were processed according to the
manufactures’ instructions.
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Estimation of lipid peroxidation 
in plasma and thymocytes
Malondialdehyde (MDA) was determined as a measurement of lipid per-
oxidation using a spectrophotometric assay for thiobarbituric acid-reac-
tive substances [15] Samples were freshly prepared from plasma and
thymus and then reacted with the mixture from the malondialdehyde
(MDA) Detection Kit (Jiancheng Biochemical Inc., Nanjing, China). After
incubation at 95°C for 40 min., the colour of the reaction turned pink.
Absorbance at 532 nm was read with a microplate reader after the reac-
tion mixture had cooled.
Detection of protein carbonyls in 
plasma and thymocytes
Protein carbonyls were assayed with the Oxyblot protein oxidation detection
kit (Chemicon International, CA, USA). The carbonyl groups in the protein
side chains were derivatized to form the 2,4,-dinitrophenylhydrazone
(DNP-hydrazone) by reaction with 2,4-dinitrophenylhydrazine (DNPH). The
DNP-derivatized protein samples were separated by polyacrylamide gel
electrophoresis followed by Western blotting [16]. Polyacrylamide resolv-
ing gels (12%, w/v) were stained with Coomassie Brilliant Blue R250, and
processed immediately for Western blotting.
Assessment of ROS production of thymocytes
ROS production by mitochondria was monitored by 2’,7’-dichlorodihydro-
fluorescein diacetate (H2DCFH-DA) [17] and analysed by flow cytometry
(FACS Calibur, Becton Dickinson). Freshly isolated thymocytes (2  106
cells) were incubated with 10 M DCFH2-DA for 30 min., then washed with
PBS. ROS levels were analysed by flow cytometry (FACSAriaTM, Becton
Dickinson) [18].
Assay of intracellular calcium 
levels in thymocytes
Intracellular calcium levels were measured by a commercially available
assay kit (Jiancheng Biochemical Inc.). Calcium reacted with methyl thy-
mol blue to form a blue complex. Optical density was measured at 610 nm
with a microplate reader.
Assay of total antioxidant capacity 
in plasma and thymocytes
The T-AOC was assayed with a commercially available kit (Jiancheng
Biochemical Inc.). The principle of the test is to measure the change in
colour following the reduction of Fe3+ to Fe2+ by the reducing compo-
nents in the samples. The reducing components may include enzymes,
and non-enzymatic molecules such as lipid-soluble antioxidant vitamin E
and water-soluble antioxidants vitamin C, uric acid, bilirubin, thiols,
gluthathione, etc. The optical density was measured at 520 nm with a
microplate reader.
Assay of reduced glutathione content in plasma
and thymocytes
Reduced GSH content was determined in both thymocytes and plasma
using a commercially available GSH Detection Kit (Jiancheng Biochemical
Inc.) using an assay based on the reaction with the thiol-specific reagent
dithionitrobenzoic acid. The adduct was measured spectrophotometrically
at 412 nm with a plate reader.
Glutathione S-transferase activity assay 
in plasma and thymocytes
Activities of the enzyme in plasma and thymocytes were measured by com-
bining 1 l plasma or 2 g protein with 1 mM GSH, 1 mM chloro-2, 4-dini-
trobenzene, 3 mg/ml BSA in 10 mM sodium phosphate buffer. The mixture
was scanned at 340 nm for 5 min. at 25°C [19].
Assay of superoxide dismutase 
in plasma and thymocytes
Total superoxide dismutase (SOD; E.C.: 1.15.1.1) activity was assayed
using a commercially available SOD Detection Kit (Jiancheng Biochemical
Inc.). The reaction is based on a xanthine and xanthine oxidase system that
produces superoxide, which in turn oxidizes hydroxylamine to nitrite,
forming a carmine coloured solution. The optical density at 550 nm was
measured by a microplate reader.
Assessment of mitochondrial membrane potential
(MMP) of thymocytes using JC-1
Determination of MMP was carried out using the fluorescent dye JC-1
(5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolylcarbocyanine iodide)
[20]. The green fluorescent JC-1 exists as a monomer (with emission at 
529 nm) at low concentrations or at low membrane potential. However, at
higher concentrations (aqueous solutions above 0.1 mM) JC-1 forms red flu-
orescent ‘J-aggregates’ that exhibit a broad excitation spectrum and an emis-
sion maximum at 590 nm. Both components of the dye are known to be sen-
sitive to MMP and changes in the ratio between green and red fluorescence
can provide information regarding the MMP. To stain cells with JC-1, 2 
106 cells were incubated with 10 g/ml of JC-1 for 15 min at 37C, then
washed twice with PBS, and analysed by a dual-wavelength/double-beam
recording spectrophotometer (Flex Station 384, Molecular Devices, USA). 
Western blot analysis of the apoptosis related
factors p53, p21 and caspase-3 in thymocytes
These soluble proteins were subjected to 10% SDS-PAGE and detected 
with primary antibodies against p53 (1:1000, Mouse mAb  No.12506, 
Santa Cruz, CA, USA), p21(1:1000, Mouse mAb  No.2946, Cell Signaling,
USA), Caspase-3 (1:1000, Rabbit mAb No. 9665, Cell Signaling, USA) 
and -tubulin (1:5000). Western blots were developed using Enhanced
Chemiluminescence (ECL) (Roche, Mannheim, Germany) and quantified
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by scanning densitometry (Bio-Rad, Hercules, CA, USA) after incubation
with horseradish peroxidase-conjugated secondary antibody. 
Statistical analysis
Data are presented as mean ± SE. Statistical significance was calculated by
SPSS 10.0 software using one-way ANOVA, and P-values <0.05 were con-
sidered significant.
Results
Splenocyte and thymocyte proliferation 
and thymus index
The proliferation of thymocytes and splenocytes of GK rats was
significantly decreased compared to that of Wistar rats (Fig. 1A
and B). At the end of the nutrient treatment, the low-dose group
showed elevated proliferation of splenocytes and thymocytes
(versus GK rats, P < 0.05 and P < 0.01, respectively), but the
pioglitazone and the high-dose groups showed no significant
effect.
The thymus index of GK rats was also significantly reduced, com-
pared with that of the Wistar rats (Fig. 1C). We observed that the cor-
tical layer of the thymus in diabetic GK rats became clearly reduced,
showing apparent atrophy. Both the low-dose group and the piogli-
tazone group demonstrated significantly higher thymus indices than
that of the non-treated GK rats (P < 0.05). These results suggest that
low-dose nutrients and pioglitazone could ameliorate or partly ame-
liorate the immune function of lymphocytes of GK rats. 
Immunomodulating parameters in plasma
As shown in Fig. 2, the plasma levels of TNF- and CRP in GK
rats were significantly higher than those in Wistar rats; the level
of plasma adiponectin in GK rats was significantly lower than that
in Wistar rats. These results indicate an increase in inflammation
in GK rats. The low-dose nutrient treatment significantly
decreased the levels of TNF- and CRP and elevated the level of
adiponectin in the GK rats; the pioglitazone treatment significantly
decreased only the level of CRP, but had no effect on the levels of
TNF- and adiponectin. The high-dose nutrient treatment had no
effect on improving the changes of any of the immunomodulating
parameters.
Oxidative damage to lipids and 
proteins in plasma and thymocytes
To test whether decreased immune function is associated with an
increase in oxidative damage, we first examined the level of lipid
peroxidation and then detected protein oxidation. The levels of
MDA in the plasma (Fig. 3A) and thymocytes (Fig. 3B) of GK rats
were significantly higher than those of Wistar rats. The low-dose
nutrient treatment showed significant reduction in the levels of
MDA in both plasma and thymocytes, while the high-dose nutrient
and pioglitazone treatments merely showed a non-significant ten-
dency to reduce MDA.
Western blots of protein carbonyls in plasma (Fig. 3C, upper)
and thymus (Fig. 3E, upper), (standardized with Coommassie blue
stained gels as an equal protein reference in plasma (Fig. 3C,
lower) and thymocytes (Fig. 3E, lower)), and the quantitative
results (Fig. 3D for plasma and 3F for thymocytes) showed that
GK rats had significantly increased protein oxidation in plasma
and thymus. All of the treatments – low dose, high dose and
pioglitazone – inhibited the increase in protein carbonyls in
plasma; while in the thymus, both low and high-dose nutrient
treatments, but not the pioglitazone treatment, significantly inhib-
ited the increase in protein carbonyls.
ROS production and intracellular 
calcium levels in thymocytes
As shown in Fig. 4A, ROS levels in the diabetic GK rats were more
than 1.5 times the Wistar rat levels (GK 150.19 ± 14.94% versus
Wistar 100%, P < 0.05). Consistent with the increase in ROS, cal-
cium levels in the diabetic GK rats were more than twice the Wistar
rat levels (GK 79.09 ± 2.92 versus Wistar 36.03 ± 2.58 mol/g pro-
tein, P < 0.01) (Fig. 4B). All treatments significantly inhibited the
increase in calcium in GK rats, and all also tended to inhibit the
ROS increases. However, only the low-dose nutrient treatment sig-
nificantly reduced the ROS levels in GK rats.
T-AOC, GSH, and the activities of antioxidant
enzymes SOD and GST in plasma and thymocytes
T-AOC levels in plasma (Fig. 5A) and thymocytes (Fig. 5B) were
significantly decreased in the GK rats, compared with the Wistar
rats. The low-dose nutrient treatment significantly inhibited the
decrease in T-AOC in both plasma and thymocytes while the
high-dose nutrient and pioglitazone treatments did not show 
significant inhibition.
Compared with the GSH levels in Wistar rats, those in the thy-
mocytes of GK rats were significantly decreased (Fig. 5D); how-
ever, GSH levels were unexpectedly increased in the plasma of GK
rats (Fig. 5C). All treatments seemed to normalize the GSH to the
levels in Wistar rats. The low-dose nutrients and pioglitazone both
normalized GSH significantly in thymocytes (Fig. 5D). The low-
dose nutrient treatment also showed a non-significant trend
toward normalization of GSH in GK rat plasma (Fig. 5C). 
Members of the phase 2 GST enzyme family catalyse the con-
jugation of reduced GSH via its sulfhydryl group, to electrophilic
centers on a wide variety of  substrates. The activation of GSTs is
© 2009 The Authors
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in the detoxification of endogenous compounds such as peroxi-
dized lipids as well as in the metabolism of xenobiotics. GST
activity in the plasma (Fig. 5E) and thymocytes (Fig. 5F) of GK
rats was significantly lower than that in Wistar rats. The low-dose
nutrient treatment significantly prevented the decrease in GST
enzyme activity in both plasma and thymocytes; the pioglitazone
treatment only showed protection in thymocytes, while the high-
dose nutrient treatment did not show protection in either plasma
or thymocytes.
The enzyme SOD catalyses the dismutation of superoxide into
oxygen and hydrogen peroxide and provides an important antioxi-
dant defence  in nearly all cells exposed to oxygen. Similar to the
changes in GST enzyme levels, GK rats, compared with Wistar rats,
had a significant decrease in SOD activity in both plasma (Fig. 5G)
and thymocytes (Fig. 5H). Similar to its effect on GST, the low-dose
nutrient treatment, like the pioglitazone treatment, significantly
inhibited the reduction in SOD activity in both plasma and thymo-
cytes in the GK rats. The high-dose nutrient treatment did not show
any protection.
Mitochondrial membrane potential in thymocytes
We examined the MMP by JC-1 fluorescence. As shown in Fig. 6,
GK rats demonstrated a significant decrease in MMP, to about half
the level in Wistar rats (51.54 ± 5.90% versus Wistar 100%, P <
0.01). Among the three treatments, only the low-dose nutrient
treatment significantly inhibited the decrease in MMP in GK rats. 
Fig. 1 Effects of treatments on thymus and spleen cell proliferation and thymus index. (A) Proliferation of thymocytes; (B) Proliferation of splenocytes
and (C) Thymus index. Data are means ± SEM of six animals (n = 6) in each group. *P < 0.05 and **P < 0.01 versus Wistar group; #P < 0.05, ##P <
0.01 versus Goto-Kakizaki (GK) untreated group.
Fig. 2 Effects of treatments on the anti-inflammatory and inflammatory factor levels in rat plasma. (A) Adiponectin; (B) Tumour necrosis factor-
(TNF-), and (C) C-reactive protein (CRP). Data are means ± SEM (n = 10). *P < 0.05 versus Wistar group; #P < 0.05 versus GK untreated group.
Apoptosis-related factors p53, p21 
and caspase-3 in thymocytes
P53 protein expression was significantly increased in the thymo-
cytes of GK rats, compared with that in Wistar rats and the increase
in p53 was accompanied by an increased expression of p21 protein
(Western blotting, Fig. 7A; quantitative results, Fig. 7B) and also
caspase 3 (Western blotting, Fig. 7C; quantitative results, Fig. 7D).
The treatment with low-dose nutrients significantly inhibited the
increase in p53, p21 and caspase-3 while the treatments with either
pioglitazone or the high-dose nutrients only significantly inhibited
the increase in p21, but not p53 nor caspase-3.
Discussion
In the present study, we found that GK rats showed decreased
immune function, decreased mitochondrial function and an
increase in oxidative damage and apoptosis factors. Low-dose
nutrient treatment effectively improved immune function,
decreased oxidative damage, enhanced mitochondrial function
and inhibited the elevation of apoptosis factors. We will discuss
the significance of these changes in relation to type 2 diabetes and
also the relations among these changes.
Immune dysfunction in type 2 diabetic GK rats
Concanavalin A (Con A)-induced mitogen responses of rat
splenocytes and thymocytes are important indices of immune
function, since the proliferation of lymphocytes correlates well
with the capacity of the immune system to fend off infections in
vivo [21]. This proliferative process leads to an increase in the
number of antigen-specific lymphocytes and is a key contributor
to the regulation, amplification and memory capabilities of the
cell-mediated immune response [21]. The proliferation of lym-
phocytes stimulated by mitogen has been applied to test immune
function in diabetic animal models [22] and in patients [23, 24].
Our results on splenocyte and thymocyte proliferation clearly
demonstrate that diabetic GK rats have a significant decrease in
proliferation of thymocytes and splenocytes. In addition, the
plasma inflammatory factors TNF- and CRP were significantly
higher while the anti-inflammatory factor adiponectin was signif-
icantly lower in the untreated GK rats compared to the Wistar
rats. These results, combined with the observed decrease in thy-
mus index, demonstrate that GK rats have decreased immune
function. These results are consistent with those observed in
another diabetic animal model [22] and in clinical diabetic
patients [23, 24]. 
Pioglitazone, a drug approved for treatment of type 2 dia-
betes, is an agonist of the peroxisome proliferator activated
receptor  (PPAR) and acts as an insulin sensitizer.
Pioglatazone and other thiazolidinediones have recently been
implicated as regulators of cellular inflammatory and immune
responses and are thought to exert anti-inflammatory effects by
negatively regulating the expression of pro-inflammatory genes
[25]. In our study, pioglitazone showed beneficial effects on
immune function in GK rats. The nutrient treatments, especially
at the lower dose, demonstrated greater beneficial effects than
pioglitazone. These results are consistent with our previous
observation that lipoic acid and acetyl-L-carnitine acted as
PPAR agonists in adipocytes [26].
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Fig. 3 Effects of treatments on lipid peroxidation (MDA) and protein oxi-
dation (carbonyls). (A) Malondialdehyde (MDA) in plasma; (B) MDA in
thymus; (C) Western blotting for protein carbonyls (upper) and
Coommassie blue staining for protein levels (lower) in plasma; (D)
Quantitative results of protein carbonyls in plasma; (E) Western blotting
for protein carbonyls (upper) and coommassie blue staining for protein
levels (lower) in thymus and (F) Quantitative results of protein carbonyls
in thymus. Data are means ± SEM (n = 8). *P < 0.05 and **P < 0.01
versus Wistar group; #P < 0.05, ##P < 0.01 versus GK untreated group.
J. Cell. Mol. Med. Vol 13, No 4, 2009
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Mitochondrial dysfunction in type 2 diabetic GK rats
Mitochondria participate in intermediary metabolism, calcium sig-
nalling and apoptosis. Therefore, it is possible that mitochondrial
dysfunction would give rise to a predictable set of defects in all tis-
sues in aging, stress, and age-associated diseases [27–29]. The GK
rat model has been shown to have mitochondrial dysfunction in the
liver [9]. In the present study, we also found GK rats to have a sig-
nificant decrease in mitochondrial function in thymocytes, com-
pared with Wistar rats. This mitochondrial dysfunction is consistent
with the increase in ROS and oxidative damage, calcium abnormality,
and decrease in antioxidant defence observed in the GK thymocytes.
Pioglitazone did not significantly improve thymocyte mitochondrial
function; however, the lower dose of nutrient treatment effectively
improved mitochondrial function in thymocytes, suggesting these
mitochondrial nutrients could directly target mitochondria.
Increased oxidants and oxidative damage 
in type 2 diabetes
Increased oxidative damage due to oxidant attack on lipids, pro-
teins and nucleic acids has been attributed to immune dysfunc-
tion. The oxidant/antioxidant balance is an important determinant
of immune and other cell functions under normal or stress con-
ditions [28, 30]. We have shown that lipid peroxidation and pro-
tein oxidation were significantly increased in the plasma and the
thymocytes of GK rats, compared to Wistar rats. Oxidative dam-
age to biomolecules such as lipids and proteins is caused by
increased ROS due to abnormally increased levels of intracellular
calcium. It was found that the GK rats do have both increased
ROS and calcium in their thymocytes. 
A second consequence of increased ROS may be the weakening of
the antioxidant defence  system by decreasing antioxidants and inacti-
vating antioxidant enzymes. We, therefore examined T-AOC, levels of
the highly important endogenous antioxidant GSH and the antioxidant
enzymes GST and SOD. All of these parameters, except GSH, con-
firmed a significant decrease in the antioxidant defence  system. 
The increase in GSH in plasma of GK rats is unexpected but is
not unusual nor unexplainable. It has been shown that GK rat liver
mitochondria show a decreased ATP/ADP ratio, accompanied by an
increase in both respiratory function and complex activity [9, 10, 31,
32]. The increased respiratory activity in liver mitochondria is con-
sidered a metabolic adaptation or adjustment to glucose injury (glu-
cose toxicity) in hepatocytes due to a decrease in ATP synthesis.
The metabolic adaptation/adjustment of liver mitochondria to glu-
cose toxicity is further indicated by the fact that GK rats, compared
to Wistar rats, have a higher level of the antioxidant coenzyme Q in
their liver mitochondria [33]. Consistent with these alterations in
liver mitochondria, we have also found that GK rats, compared to
Wistar rats, show a significant increase in GSH in liver mitochondria
(GK 112% versus Wistar 100%, P < 0.05, unpublished). The
increase in liver GSH provides an explanation for the increased GSH
level in plasma. Nevertheless, it is interesting to note that the low-
dose nutrient treatment restores GSH levels in both plasma and thy-
mus. This suggests that the nutrient treatment may strengthen liver
mitochondrial function and antioxidant defences, and thus make the
cells more resistant to environmental challenges.
Oxidative damage, mitochondrial dysfunction and
apoptosis may be a cause of immune dysfunction
The development of type 2 diabetes is accompanied by decreased
immune function, but the mechanisms are unclear. We propose
that mitochondrial dysfunction may be one of the major causes of
immune dysfunction in GK rats. Oxidative stress induces mito-
chondrial dysfunction and also apoptosis. Activation of caspase-3
as a consequence of mitochondrial membrane depolarization has
been shown to result from both in vitro and in vivo cytotoxic treat-
ments [34]. Apoptosis causes immune suppression by inducing
depletion of various immune cells, resulting in the loss of key anti-
microbial functions, and impairing immunity by inducing immuno-
suppressive effects in the surviving cells [35]. The p53 tumour
suppressor gene product plays an important role in the regulation
of apoptosis through either caspase-dependent or independent
Fig. 4 Effect of treatments on reactive
oxygen species (ROS) and calcium levels
in the thymus. (A) ROS levels, and (B)
Calcium levels. Data are means ± SEM 
(n = 10). *P < 0.05 and **P < 0.01 ver-
sus. Wistar group; #P < 0.05, ##P < 0.01
versus GK untreated group.
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pathways and concomitant upregulation of cyclin-dependent
kinase inhibitor p21 [36]. The enhanced expression of p53 and the
accompanying increases in p21 and caspase-3 suggest that the
decreased immune function and the suppression of cell prolifera-
tive mitogenic response in GK rats are mediated by mitochondrial
caspase-dependent apoptosis in the thymus. Nevertheless, a cas-
pase-independent pathway may also be operative since the
increases in intracellular calcium, ROS, oxidative damage to lipids
and proteins and mitochondrial impairment all favour a possible
release of apoptosis inducing factor [34].
It was shown that in activated, proliferative T cells, inhibi-
tion of apoptosis mediated by NF-	B–prevents destruction of
the proliferating T cells. However, mitochondrial membrane
depolarization initiates apoptosis, and ROS vitiate NF-	B’s
ability to inhibit it [37], resulting in T-cell destruction and a
weakened proliferative capacity. This provides direct evidence
linking the depressed MMP and increased ROS levels in the
GK rat thymocytes and splenocytes with their decreased pro-
liferative capacity. 
Therefore, increased oxidants cause mitochon-drial dysfunc-
tion, which causes more production of oxidants and oxidative dam-
age. This vicious cycle may ultimately cause cell death and lead to
dysfunction of the immune system. This proposed mechanism is
tested by the nutrient treatments as stated below.
© 2009 The Authors
Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 5 Effect of treatments on the total antioxidant capacities (T-AOC), glutathione (GSH), glutathione S-transferase (GST), and superoxide dismutase
(SOD) in plasma and thymus. (A) T-AOC in plasma, n = 6; (B) T-AOC in thymus, n = 6; (C) GSH in plasma, n = 10; (D) Glutathione (GSH) in thymus, n
= 8; (E) glutathione S-transferase (GST) in plasma, n = 10; (F) GST in thymus, n = 10; (G) Superoxide dismutase (SOD) in plasma, n = 10 and (H) SOD
in thymus, n = 10. Data are means ± SEM. *P < 0.05 and **P < 0.01 versus Wistar group; #P < 0.05, ##P < 0.01 versus GK untreated group.
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Rationale for choosing the mitochondrial nutrients
The rationale for choosing for choosing these four mitochondrial
nutrients is briefed as below. LA is a mitochondrial nutrient able to
scavenge free radicals, chelate iron to prevent the generation of
free radicals, induce phase 2 enzymes, stimulate mitochondrial
biogenesis and act as a cofactor of pyruvate dehydrogenase and
lipoamide dehydrogenase [12, 38]. Lipoic acid has been used for
treatment of diabetes complications, such as neuropathy [39].
Acetyl-L-carnitine has been shown to be effective for improving
insulin-mediated glucose disposal either in healthy subjects or in
type 2 diabetic patients [40, 41]. We [26] have recently found that
lipoic acid and acetyl-L-carnitine, individually and in combination,
stimulate mitochondrial biogenesis in 3T3-L1 adipocytes. The
combination is about 10–100 times as potent as either compound
administered alone, suggesting a potent synergistic action [26].
Finally, an important factor in choosing lipoic acid and acetyl-L-car-
nitine in combination was their synergistic ability to improve mito-
chondrial function, ambulatory activity and cognition in old rats
[42–44] and beagles [45].
Two reasons were behind our inclusion of biotin. First, four of
the five biotin-dependent carboxylases are in the mitochondria.
Second, a high intake of biotin may exert effects on  cells, liver
and skeletal muscle, that favour good glucose tolerance [46].
Pancreatic islet dysfunction is an important feature of GK
pathogenesis [6, 47]. Niacin appears to protect against the loss
of  cell function in type 1 diabetes [48, 49]. The other main value
of niacin supplementation is to increase the availability of this B
vitamin in its role as component of the coenzymes NADH and
NADPH, both of which are essential for proper mitochondrial
function. NAD(P)H acts as a donor of hydrogen anion in a 
variety of enzymatic processes, such as the reduction of lipoic
acid to dihydro-lipoic acid [50]. In addition, Kirsch and De Groot
[51] have proposed that NAD(P)H may also act as a directly 
operating antioxidant.
Based on the above facts, we have proposed that the rational
combination of mitochondria-targeted nutrients may complemen-
tarily promote mitochondrial synthesis and adipocyte metabolism
and possibly prevent and treat insulin resistance in type 2 diabetes,
and our results for the treatments with these four nutrients do sup-
port this hypothesis. Consistent with the effects of low-dose treat-
ment on glucose tolerance, fatty acid metabolism, and muscle
mitochondrial biogenesis and function in GK rats, the effects of
treatment at this dosage seem comparable to, or even more effec-
tive than, pioglitazone treatment. Conversely, the 10-fold higher
dose of these same mitochondrial nutrients, though not toxic,
loses most of the beneficial effects of the low dose, except for the
improvements in thymus MDA, plasma and thymus protein car-
bonyls, thymus calcium, and p21 expression. The decreased effec-
tiveness of the high dose is possibly because it is an overdose that
overshoots the optimal point in a bell-shaped dose–effect curve.
These data suggest that a rational combination of mitochondrial-
targeting nutrients in the proper dose may be used clinically for
ameliorating immune dysfunction in patients with type 2 diabetes.
Although we have termed these nutrients mitochondrial-target-
ing agents and focused on the their effects in mitochondria, it
should be borne in mind that the four nutrients used are essential
for non-mitochondrial cell functions as well. For example,
although lipoic acid is a mitochondrial cofactor and mainly located
in mitochondria, it is also available to and influences many activi-
ties in other parts of the cell when supplied exogenously.
Conclusion
In conclusion, we have shown that GK rats, compared to Wistar
rats, have a decrease in immune function and an increase in oxida-
tive damage, mitochondrial dysfunction and apoptosis-related fac-
tors in the plasma, spleen and thymus. A 12-week-long treatment
with a combination of mitochondrial-targeting nutrients in the GK
rats effectively ameliorated their immune and mitochondrial dys-
function, inhibited oxidative damage, and reversed the enhanced
apoptosis process. The significant beneficial effects of mitochon-
drial-targeting nutrients on diabetes-associated immune dysfunc-
tion suggest that this modern nutrition-related disease possibly
may be controlled by appropriate manipulation with nutrients,
rather than exclusively by drugs.
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